Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
zhenming guo
(39 results)?
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies.
Biomark Res. 2020 May 27;8:18. doi: 10.1186/s40364-020-00197-1. eCollection 2020.
Biomark Res. 2020.
PMID: 32514351
Free PMC article.
Review.
Preclinical and clinical advances in dual-target chimeric antigen receptor therapy for hematological malignancies.
Guo Z, Tu S, Yu S, Wu L, Pan W, Chang N, Zhou X, Song C, Li Y, He Y.
Guo Z, et al.
Cancer Sci. 2021 Apr;112(4):1357-1368. doi: 10.1111/cas.14799. Epub 2021 Feb 21.
Cancer Sci. 2021.
PMID: 33416209
Free PMC article.
Review.
Item in Clipboard
The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study.
Han S, Zhou L, Chen Y, Zhou X, Guo Z, Yang J, Jin B, Liu Y, Chang LJ, Li Y, Tu S.
Han S, et al. Among authors: guo z.
Bone Marrow Transplant. 2022 Mar;57(3):513-516. doi: 10.1038/s41409-022-01572-2. Epub 2022 Jan 20.
Bone Marrow Transplant. 2022.
PMID: 35058582
No abstract available.
Item in Clipboard
Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.
Tu S, Huang R, Guo Z, Deng L, Song C, Zhou X, Yue C, Zhang L, He Y, Yang J, Liang Z, Du J, Cao P, Li Y, Chang LJ, Li Y.
Tu S, et al. Among authors: guo z.
Am J Hematol. 2019 Dec;94(12):E322-E325. doi: 10.1002/ajh.25630. Epub 2019 Oct 2.
Am J Hematol. 2019.
PMID: 31489688
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Zhou X, Tu S, Wang C, Huang R, Deng L, Song C, Yue C, He Y, Yang J, Liang Z, Wu A, Li M, Zhou W, Du J, Guo Z, Li Y, Jiao C, Liu Y, Chang LJ, Li Y.
Zhou X, et al. Among authors: guo z.
Front Immunol. 2020 Nov 27;11:564099. doi: 10.3389/fimmu.2020.564099. eCollection 2020.
Front Immunol. 2020.
PMID: 33329526
Free PMC article.
Clinical Trial.
Item in Clipboard
CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
Tu S, Zhou X, Guo Z, Huang R, Yue C, He Y, Li M, Chen Y, Liu Y, Chang LJ, Li Y.
Tu S, et al. Among authors: guo z.
Front Oncol. 2019 Dec 4;9:1350. doi: 10.3389/fonc.2019.01350. eCollection 2019.
Front Oncol. 2019.
PMID: 31867275
Free PMC article.
Item in Clipboard
Cite
Cite